Medicare Enrolled

Michael Neuland, M. D.

Allergy & Immunology · Ft Walton Bch, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
339 RACETRACK RD NW, Ft Walton Bch, FL 32547
8508631189
Registered in NPPES since 2005
NPI: 1467442525 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Neuland from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Neuland? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Neuland

Michael Neuland is an allergy & immunology specialist in Ft Walton Bch, FL, with 20 years of NPI registration. Based on federal Medicare data, Neuland performed 16,756 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Neuland received a total of $20,326 from 39 pharmaceutical and/or device companies across 840 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Neuland is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 17% volume in FL $20,326 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 79611 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
16,756
Medicare services
Top 17% in FL for allergy & immunology
Not available
Unique patients (not deduplicated)
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Omalizumab injection (Xolair) for asthma/allergy 4,965 $30 $71
Allergy skin test
A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens.
4,956 $3 $14
Allergy immunotherapy preparation
A professional service involving the preparation and administration of one or more antigens.
2,285 $9 $29
Injection, benralizumab, 1 mg 1,560 $133 $359
Allergy injection therapy, multiple injections
A professional service involving the administration of multiple allergen injections.
645 $8 $39
Allergen injection administration
Professional service for the administration of a single allergen injection.
415 $7 $29
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
409 $10 $55
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
308 $62 $148
Health risk assessment administration and interpretation
This procedure involves administering a health risk assessment to a patient and interpreting the results.
298 $2 $14
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
222 $92 $231
Allergy test using drug or biological combination
A diagnostic procedure to identify allergic reactions by testing a combination of methods using a specific drug or biological agent.
154 $15 $40
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
123 $112 $313
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
119 $18 $81
Nitric oxide gas level test
A test that measures the level of nitric oxide gas in the body.
84 $14 $37
Skin allergy test
A test where small amounts of potential allergens are injected into the skin to check for allergic reactions.
77 $6 $15
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
35 $29 $133
Inhalation treatment for airway obstruction or sputum production
A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production.
32 $7 $34
New patient office visit, complex (60-74 min) 29 $160 $402
Middle ear function test
A diagnostic test used to evaluate how well the middle ear is functioning.
21 $12 $31
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
19 $17 $38
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$20,326
Total received (2018-2024)
Avg $2,904/year across 7 years
Top 18% in FL for allergy & immunology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
840
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,563
2023
$3,050
2022
$3,487
2021
$3,471
2020
$2,176
2019
$2,173
2018
$2,406

Payments by company (2024)

AstraZeneca Pharmaceuticals LP
$573
CSL Behring
$456
Regeneron Healthcare Solutions, Inc.
$450
GlaxoSmithKline, LLC.
$374
Grifols USA, LLC
$294
GENZYME CORPORATION
$258
Amgen Inc.
$249
Pharming Healthcare, Inc.
$221
Takeda Pharmaceuticals U.S.A., Inc.
$187
Blueprint Medicines Corporation
$116
Genentech USA, Inc.
$108
Octapharma USA, Inc.
$82
PFIZER INC.
$58
Vifor Pharma, Inc.
$53
BioCryst US Sales Co., LLC
$43
Insmed, Inc.
$24
Hikma Pharmaceuticals USA
$17
Top 3 companies account for 41.5% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$3,972
GlaxoSmithKline, LLC.
$3,818
Regeneron Healthcare Solutions, Inc.
$1,780
GENZYME CORPORATION
$1,761
CSL Behring
$1,627
Grifols USA, LLC
$1,368
Pharming Healthcare, Inc.
$844
Genentech USA, Inc.
$654
Octapharma USA, Inc.
$594
Amgen Inc.
$583
Takeda Pharmaceuticals U.S.A., Inc.
$453
PFIZER INC.
$396
kaleo, Inc.
$304
BioCryst US Sales Co., LLC
$286
Horizon Therapeutics plc
$240
ABBVIE INC.
$216
Blueprint Medicines Corporation
$205
Boehringer Ingelheim Pharmaceuticals, Inc.
$205
Novartis Pharmaceuticals Corporation
$195
Shire North American Group Inc
$181
Sunovion Pharmaceuticals Inc.
$89
SANOFI-AVENTIS U.S. LLC
$65
Optinose US, Inc.
$56
Vifor Pharma, Inc.
$53
OptiNose US, Inc.
$53
Teva Pharmaceuticals USA, Inc.
$38
Merck Sharp & Dohme LLC
$35
LEO Pharma Inc.
$33
Hikma Pharmaceuticals USA
$31
Aimmune Therapeutics, Inc.
$25
Insmed, Inc.
$24
Incyte Corporation
$21
BioCryst Pharmaceuticals, Inc.
$21
ADMA BioManufacturing LLC
$20
Circassia Pharmaceuticals Inc
$18
ALK-Abello, Inc
$17
Merck Sharp & Dohme Corporation
$16
Kaleo, Inc.
$15
Horizon Pharma plc
$15
Top 3 companies account for 47.1% of all-time payments
Associated products mentioned in payments ›
ACTIMMUNE · ADBRY · AIRSUPRA · ARALAST · AUVI-Q · AYVAKIT · AirDuo Digihaler · Arikayce · ArmonAir Digihaler · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CIBINQO · CUTAQUIG · CUVITRU · DERMATITIS - DISEASE · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENTRESTO · EUCRISA · FARXIGA · FASENRA · FIRAZYR · GATTEX · GLASSIA · Gamunex-C · HYQVIA · Haegarda · Hizentra · ILARIS · LONHALA MAGNAIR · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · ORLADEYO · Orladeyo · Otiprio · PALFORZIA · PANZYGA · Prolastin-C · Prolastin-C Liquid · RINVOQ · RUCONEST · Ryaltris · SPIRIVA · SPIRIVA RESPIMAT · SYMBICORT · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · XOLAIR · Xembify · Xhance · Xolair · Zemaira
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an allergy & immunology specialist in Ft Walton Bch?
Compare allergy & immunologists in the Ft Walton Bch area by procedure volume, costs, and industry payment transparency.
Browse allergy & immunologists nearby

Geographic Context

Allergy & immunologists in nearby ZIP areas
6
County median income
$79,097
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA FORT WALTON-DESTIN HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Neuland is a mixed practice specialist, with above-average Medicare volume (top 17% in FL), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Neuland experienced with omalizumab injection (xolair) for asthma/allergy?
Based on Medicare claims data, Neuland performed 4,965 omalizumab injection (xolair) for asthma/allergy services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Neuland receive payments from pharmaceutical companies?
Yes. Neuland received a total of $20,326 from 39 companies across 840 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Neuland's costs compare to other allergy & immunologists in Ft Walton Bch?
Neuland's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Neuland) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →